Pharmaceuticals News and Research

RSS

Top line results from Zalicus Synavive Phase 2b study in rheumatoid arthritis

Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced top line results from its randomized, double-blind, placebo-controlled, Phase 2b clinical trial of Synavive in rheumatoid arthritis.

10 Sep 2012

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

BioLineRx, a biopharmaceutical development company, announced today that BL-7010, an orally available treatment for celiac disease, was found to be safe and well tolerated in pre-clinical studies conducted to date.

10 Sep 2012

GSK, University of Cambridge aim to discover and develop new medicines for liver disease

A new collaboration based at the University of Cambridge will aim to discover and develop new medicines to treat liver disease.

10 Sep 2012

UC Irvine receives CIRM grant to advance stem cell-based treatments for AD, retinitis pigmentosa

Efforts to begin human clinical trials using stem cells to treat Alzheimer's disease and retinitis pigmentosa received a $37.3 million boost from the California Institute for Regenerative Medicine during its most recent round of funding on Sept. 5.

10 Sep 2012

Viewpoints: Obama's 'talk of tough choices'; Championing personal responsibility

And he clearly laid out a vision for governing squarely at odds with the one that Mr. Romney has, but was hidden from view at last week's Republican convention in Tampa, Fla. He promised deficit reduction "without sticking it to the middle class"; to enact a reformed tax code that raises rates on income above $250,000 to where it was under Mr. Clinton; to preserve middle-class deductions; to "never turn Medicare into a voucher."

7 Sep 2012

Strategic roadmap to help cope with impending Alzheimer's disease public health crisis

This week, a strategic roadmap to help to the nation's health care system cope with the impending public health crisis caused Alzheimer's disease and related dementia will be published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

7 Sep 2012

Pfizer announces settlement of Detrol LA patent litigation with Mylan

Pfizer Inc. announced that it has settled its litigation against Mylan Inc. and Mylan Pharmaceuticals Inc. relating to Pfizer's patents covering Detrol LA (tolterodine tartrate) extended-release capsules.

7 Sep 2012

Pfizer, Mylan enter settlement agreement to resolve generic Detrol LA litigation

Mylan Inc. today announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB that will resolve the parties' patent litigation in connection with Mylan Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Tolterodine Tartrate ER capsules, 2 mg and 4 mg, which is the generic version of Pfizer's Detrol LA, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

7 Sep 2012

OncoMed announces data from demcizumab preclinical study on pancreatic cancer

OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.

7 Sep 2012

The Institute of Cancer Research, CRT and Astex to discover and develop novel drug candidates

Astex Pharmaceuticals, Inc, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, Cancer Research Technology Limited (CRT) and The Institute of Cancer Research, London, have initiated a collaboration to discover and develop drug candidates targeting an undisclosed epigenetic target in a blood cancer with high unmet medical need.

7 Sep 2012

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.

7 Sep 2012

Kalidex announces presentation of data on KPI-10 against MDR strains at ICAAC

Kalidex Pharmaceuticals, a privately-held anti-infective company, today announced the presentation of data on its lead development candidate KPI-10, a broad spectrum, next-generation fluoroquinolone, at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, September 9 through 12.

7 Sep 2012

Longer looks: Insurers balk at price of new asthma relief; Despite health law, costs still overwhelming for some patients

For two decades, Patricia DiGiusto struggled with severe asthma. Powerful medications and frequent use of her inhaler could not prevent repeated trips to the emergency room. ... Two years ago, Ms. DiGiusto's doctor told her about a new procedure called bronchial thermoplasty, the first non-drug therapy approved by the Food and Drug Administration for patients with severe asthma.

7 Sep 2012

Clathrin protein plays a key role in cell division

A protein called "clathrin," which is found in every human cell and plays a critical role in transporting materials within them, also plays a key role in cell division, according to new research at the University of California, San Francisco.

7 Sep 2012

Viewpoints: Clinton's rousing support for Medicare, health law; Thalidomide and the struggle for an abortion; Arkansas health innovations

Clinton, once known for the strategy of "triangulation" between the parties, was among the speakers who answered Patrick's call. He assailed Romney and Paul Ryan for falsehoods on welfare and Medicare, dismantling one Tampa argument after another. Offering a vision of "shared responsibilities, shared prosperity [and] a shared sense of community," he stoutly defended Obama's health care law, student loan reforms, rescue of the auto industry, commitments to community colleges and job training, and budget proposals.

7 Sep 2012

Ingenuity Systems, ShanghaiBio sign collaboration agreement

ShanghaiBio Corporation and Ingenuity Systems have signed a collaboration agreement enabling ShanghaiBio Corporation to extend its current lab service offering to include Ingenuity solutions for downstream analysis and interpretation of genomics data. ShanghaiBio Corporation will complement their sequencing, genotyping and gene expression lab services by creating a bundled solution with Ingenuity's applications, which combine analytics and biomedical content to help get actionable insights from experiments.

6 Sep 2012

Congressional champion for brain science research issues statement in response to $30M NFL grant

Congressman Chaka Fattah (D-PA), the Congressional champion for brain science research and author of the Fattah Neuroscience Initiative, issues this statement in response to today's $30 million grant by the National Football League to the Foundation for the National Institutes of Health.

6 Sep 2012

Clinical trial to test combination of two drugs in treating fibromyalgia

A chronic pain condition and numerous gastrointestinal disorders may all be caused by a virus. That's a Tuscaloosa-based surgeon's theory likely headed for a clinical trial early next year and one drawing support from a University of Alabama researcher who studies how viruses replicate.

6 Sep 2012

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

AMAG Pharmaceuticals, Inc. today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease.

6 Sep 2012

FDA continues review of Salix’s Crofelemer new drug application

Napo Pharmaceuticals, Inc. was informed today that the Food and Drug Administration is continuing its review of the new drug application seeking approval of crofelemer for the treatment of chronic diarrhea in people living with HIV/AIDS on anti-retroviral therapy.

6 Sep 2012

Pharmaceuticals News and Research

Top line results from Zalicus Synavive Phase 2b study in rheumatoid arthritis

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

GSK, University of Cambridge aim to discover and develop new medicines for liver disease

UC Irvine receives CIRM grant to advance stem cell-based treatments for AD, retinitis pigmentosa

Viewpoints: Obama's 'talk of tough choices'; Championing personal responsibility

Strategic roadmap to help cope with impending Alzheimer's disease public health crisis

Pfizer announces settlement of Detrol LA patent litigation with Mylan

Pfizer, Mylan enter settlement agreement to resolve generic Detrol LA litigation

OncoMed announces data from demcizumab preclinical study on pancreatic cancer

The Institute of Cancer Research, CRT and Astex to discover and develop novel drug candidates

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

Kalidex announces presentation of data on KPI-10 against MDR strains at ICAAC

Longer looks: Insurers balk at price of new asthma relief; Despite health law, costs still overwhelming for some patients

Clathrin protein plays a key role in cell division

Viewpoints: Clinton's rousing support for Medicare, health law; Thalidomide and the struggle for an abortion; Arkansas health innovations

Ingenuity Systems, ShanghaiBio sign collaboration agreement

Congressional champion for brain science research issues statement in response to $30M NFL grant

Clinical trial to test combination of two drugs in treating fibromyalgia

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

FDA continues review of Salix’s Crofelemer new drug application

A guide to density measurement excellence eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence